- Home
- YSS vs ACLX Comparison
YSS vs ACLX Comparison
Compare YSS & ACLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
N/A
Current Price
$23.15
HOLD
Current Price
$114.60
Company Overview
Basic Information| Metric | YSS | ACLX |
|---|---|---|
| Founded | 2012 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Military/Government/Technical | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.2B | 3.7B |
| IPO Year | N/A | 2022 |
Fundamental Metrics
Financial Performance| Metric | YSS | ACLX |
|---|---|---|
| Price | $23.15 | $114.60 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 9 | 15 |
| Target Price | $37.22 | ★ $115.85 |
| AVG Volume (30 Days) | 938.9K | ★ 3.7M |
| Earning Date | 03-19-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $22,286,000.00 |
| Revenue This Year | $48.59 | $397.53 |
| Revenue Next Year | $54.23 | $123.06 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $16.93 | $47.86 |
| 52 Week High | $34.36 | $114.91 |
Technical Indicators
Market Signals| Indicator | YSS | ACLX |
|---|---|---|
| Relative Strength Index (RSI) | 50.16 | 82.41 |
| Support Level | $22.01 | $66.06 |
| Resistance Level | $23.60 | $114.80 |
| Average True Range (ATR) | 1.82 | 0.32 |
| MACD | 0.13 | -1.51 |
| Stochastic Oscillator | 82.61 | 63.09 |
Price Performance
Historical Comparison YSS
ACLX
About ACLX Arcellx Inc.
Arcellx Inc a clinical-stage biotechnology company reimagining cell therapy through the development of immunotherapies for patients with cancer and other incurable diseases. Its pipeline includes Multiple Myeloma, Acute Myeloid Leukemia, Non-Oncology, and Solid Tumors.